Letter: how can we reduce mortality in elderly patients with acute severe ulcerative colitis? Authors' reply
Aliment Pharmacol Ther
.
2020 Jun;51(12):1445-1446.
doi: 10.1111/apt.15776.
Authors
Catherine Dong
1
,
Marie Metzger
2
,
Einar E Holsbø
3
,
Vittorio Perduca
4
,
Franck Carbonnel
1
Affiliations
1
Department of Gastroenterology, Hôpital de Bicêtre, Assistance Publique-Hôpitaux de Paris, Université Paris Saclay, Le Kremlin-Bicêtre, France.
2
Inserm U1018, Centre for Research in Epidemiology and Population Health, Paris Saclay University, Villejuif, France.
3
Department of Computer Science, UiT - The Arctic University of Norway, Tromsø, Norway.
4
MAP5 Laboratory (UMR CNRS 8145), Université Paris Descartes, Université de Paris, Paris, France.
PMID:
32445525
DOI:
10.1111/apt.15776
No abstract available
Publication types
Letter
Comment
MeSH terms
Aged
Colitis, Ulcerative*
Humans
Immunosuppressive Agents
Substances
Immunosuppressive Agents